Ling Geoffrey M.D. 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jun 12, 2020
Insider Transaction Report
Form 4
Ling Geoffrey M.D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-11+5,000→ 5,000 totalExercise: $7.18Exp: 2030-06-11→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option shall vest monthly over a period of 12 months commencing June 11, 2020.